How the immunoassay transformed C-peptide from a duckling into a swan

Diabetologia

Volumn 55, Issue 4, 2012, Pages 865-869

  Roth, J ^a,b,e   Whitford, I ^a   Dankner, R ^a,c,d   Szulc, A L ^a,b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e NONE   (United States)

Author keywords

C peptide; C peptide history; Diabetes; Diabetic nephropathy; Diabetic neuropathy; Early diagnosis of diabetes; Immunoassay; Insulin

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ANTIBODY; PROINSULIN;

ANTIBODY PRODUCTION; ARTICLE; CELL LOSS; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIET RESTRICTION; EARLY DIAGNOSIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTORY OF MEDICINE; HORMONE DETERMINATION; HORMONE STRUCTURE; HUMAN; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 84862571928     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2421-0     Document Type: Article

References (27)

1. von Mering J, Minkowski O (1889) Diabetes Mellitus nach Pankreasextirpation. Arch Exp Path u Pharmakol 26:371-387 (article in German)
2. De Meyer J (1909) Action de la sécrétion interne du pancréas sur différents organes et en particulier sur la sécrétion rénale. Arch Fisiol 7:96-99 (article in French)
3. Bliss M (1982) The discovery of insulin. McClelland and Stewart Limited, Toronto
4. Yalow RS, Berson SA (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39:1157-1175
5. Roth J (2011) A tribute to Rosalyn S. Yalow. J Clin Invest 121:2949-2951
6. Steiner DF, Oyer PE (1967) The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 57:473-480
7. Steiner DF (2011) Adventures with insulin in the islets of Langerhans. J Biol Chem 286:17399-17421
8. Steiner DF (2004) The proinsulin C-peptide\a multirole model. Exp Diabesity Res 5:7-14
9. Roth J, Gorden P, Pastan I (1968) "Big insulin": a new component of plasma insulin detected by immunoassay. Proc Natl Acad Sci USA 61:138-145
10. Rubenstein AH, Cho S, Steiner DF (1968) Evidence for proinsulin in human urine and serum. Lancet 1:1353-1355
11. Heding LG (1972) Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8:260-266
12. Heding LG (1971) Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7:10-19
13. Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11:541-548
14. Terris S, Steiner DF (1976) Retention and degradation of I-insulin by perfused livers from diabetic rats. J Clin Invest 57:885-896
15. Zeleznik AJ, Roth J (1978) Demonstration of the insulin receptor in vivo in rabbits and its possible role as a reservoir for the plasma hormone. J Clin Invest 61:1363-1374
16. Brandenburg D (2008) History and diagnostic significance of C-peptide. Exp Diabetes Res 2008:576862
17. Ludvigsson J, Heding LG (1976) C-peptide in children with juvenile diabetes. A preliminary report. Diabetologia 12:627-630
18. Koch CA, Rother KI, Roth J (1999) Tumor hypoglycemia linked to IGF-II. In: Rosenfeld RG, Roberts CT (eds) The IGF system: molecular biology, physiology, and clinical applications. Humana Press, Totowa, pp 675-698
19. Dankner R, Danoff A, Roth J (2010) Can 'personalized diagnostics' promote earlier intervention for dysglycaemia? Hypothesis ready for testing. Diabetes Metab Res Rev 26:7-9
20. Dankner R, Chetrit A, Shanik MH, Raz I, Roth J (2009) Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care 32:1464-1466
21. Wahren J, Ekberg K, Jornvall H (2007) C-peptide is a bioactive peptide. Diabetologia 50:503-509
22. Sima AA, Zhang W, Sugimoto K et al (2001) C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 44:889-897
23. Samnegard B, Jacobson SH, Jaremko G et al (2005) C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20:532-538
24. Luppi P, Cifarelli V, Wahren J (2011) C-peptide and long-term complications of diabetes. Pediatr Diabetes 12:276-292
25. Sima AAF (ed) (2011) Diabetes and C-peptide. Scientific and clinical aspects. Humana Press, New York
26. Ludvigsson J (2009) Lise G Heding, 1936-2008. Diabetologia 52:2245-2246
27. 'Ugly duckling' (1953) In: Webster's New Collegiate Dictionary GC Merriam Co., Springfield